{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:18:50Z","timestamp":1778879930652,"version":"3.51.4"},"reference-count":236,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Sanofi Pharmaceuticals"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,25]]},"abstract":"Abstract<\/jats:title>Introduction<\/jats:title>Prior consensus meetings have addressed the relationship between phosphodiesterase type 5 (PDE5) inhibition and cardiac health. Given significant accumulation of new data in the past decade, a fourth consensus conference on this topic was convened in Pasadena, California, on March 10 and 11, 2023.<\/jats:p><\/jats:sec>Objectives<\/jats:title>Our meeting aimed to update existing knowledge, assess current guidelines, and make recommendations for future research and practice in this area.<\/jats:p><\/jats:sec>Methods<\/jats:title>An expert panel reviewed existing research and clinical practice guidelines.<\/jats:p><\/jats:sec>Results<\/jats:title>Key findings and clinical recommendations are the following: First, erectile dysfunction (ED) is a risk marker and enhancer for cardiovascular (CV) disease. For men with ED and intermediate levels of CV risk, coronary artery calcium (CAC) computed tomography should be considered in addition to previous management algorithms. Second, sexual activity is generally safe for men with ED, although stress testing should still be considered for men with reduced exercise tolerance or ischemia. Third, the safety of PDE5 inhibitor use with concomitant medications was reviewed in depth, particularly concomitant use with nitrates or alpha-blockers. With rare exceptions, PDE5 inhibitors can be safely used in men being treated for hypertension, lower urinary tract symptoms and other common male disorders. Fourth, for men unresponsive to oral therapy or with absolute contraindications for PDE5 inhibitor administration, multiple treatment options can be selected. These were reviewed in depth with clinical recommendations. Fifth, evidence from retrospective studies points strongly toward cardioprotective effects of chronic PDE5-inhibitor use in men. Decreased rates of adverse cardiac outcomes in men taking PDE-5 inhibitors has been consistently reported from multiple studies. Sixth, recommendations were made regarding over-the-counter access and potential risks of dietary supplement adulteration. Seventh, although limited data exist in women, PDE5 inhibitors are generally safe and are being tested for use in multiple new indications.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>Studies support the overall cardiovascular safety of the PDE5 inhibitors. New indications and applications were reviewed in depth.<\/jats:p><\/jats:sec>","DOI":"10.1093\/sxmrev\/qeae043","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:13:38Z","timestamp":1719533618000},"page":"681-709","source":"Crossref","is-referenced-by-count":4,"title":["Proceedings of PRINCETON IV: PDE5 inhibitors and cardiac health symposium"],"prefix":"10.1093","volume":"12","author":[{"given":"Raymond C","family":"Rosen","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences , , San Francisco, 401 Parnassus Ave, San Francisco, CA 94143 ,","place":["United States"]},{"name":"University of California , , San Francisco, 401 Parnassus Ave, San Francisco, CA 94143 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Miner","sequence":"additional","affiliation":[{"name":"Men\u2019s Health Center , , 180 Corliss St. 2nd Floor, Providence, RI 02904 ,","place":["United States"]},{"name":"Miriam Hospital , , 180 Corliss St. 2nd Floor, Providence, RI 02904 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur L","family":"Burnett","sequence":"additional","affiliation":[{"name":"Department of Urology , Ciccarone Center for Clinical Research, , 600 N Wolfe St # B110, Baltimore, MD 21287 ,","place":["United States"]},{"name":"Johns Hopkins University , Ciccarone Center for Clinical Research, , 600 N Wolfe St # B110, Baltimore, MD 21287 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J","family":"Blaha","sequence":"additional","affiliation":[{"name":"Department of Cardiology , , Lutherville, 10755 Falls Road, Lutherville, MD 21093 ,","place":["United States"]},{"name":"Johns Hopkins Health Care & Surgery Center, Green Spring Station , , Lutherville, 10755 Falls Road, Lutherville, MD 21093 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Ganz","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Vascular Research , , San Francisco, 1001 Potrero Ave # 107, San Francisco, CA 94110 ,","place":["United States"]},{"name":"University of California , , San Francisco, 1001 Potrero Ave # 107, San Francisco, CA 94110 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irwin","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Institute for Sexual Medicine , 5555 Reservoir Dr # 300, San Diego, CA 92120 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Kim","sequence":"additional","affiliation":[{"name":"Institute for Sexual Medicine , 5555 Reservoir Drive, Suite 300, San Diego, CA 92120 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Kohler","sequence":"additional","affiliation":[{"name":"Dept of Urology , , 200 First St. S.W., Rochester, Minnesota 55905, US ,","place":["United States"]},{"name":"Mayo Clinic , , 200 First St. S.W., Rochester, Minnesota 55905, US ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Lue","sequence":"additional","affiliation":[{"name":"Department of Urology , , San Francisco, School of Medicine, 400 Parnassus Ave #610, San Francisco, CA 94143 ,","place":["United States"]},{"name":"University of California , , San Francisco, School of Medicine, 400 Parnassus Ave #610, San Francisco, CA 94143 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"McVary","sequence":"additional","affiliation":[{"name":"Center for Male Health , Stritch School of Medicine, , 6800 N Frontage Rd, Burr Ridge, IL 60527 ,","place":["United States"]},{"name":"Loyola University , Stritch School of Medicine, , 6800 N Frontage Rd, Burr Ridge, IL 60527 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Mulhall","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center , , 205 E 64th St, New York, NY 10065 ,","place":["United States"]},{"name":"Sloan Kettering Hospital , , 205 E 64th St, New York, NY 10065 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon J","family":"Parish","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College , 21 Bloomingdale Rd, White Plains, NY 10605 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Sadeghi-Nejad","sequence":"additional","affiliation":[{"name":"Professor of Urology and Ob-Gyn , Department of Urology, Langone Grossman School of Medicine, , 222 East 41st Street, 12th Floor, New York, NY 10017 ,","place":["United States"]},{"name":"New York University , Department of Urology, Langone Grossman School of Medicine, , 222 East 41st Street, 12th Floor, New York, NY 10017 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Sadovsky","sequence":"additional","affiliation":[{"name":"Dept of Family Medicine , , 450 Clarkson Ave, Brooklyn, NY 11203 ,","place":["United States"]},{"name":"Downstate Medical Center , , 450 Clarkson Ave, Brooklyn, NY 11203 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira","family":"Sharlip","sequence":"additional","affiliation":[{"name":"Department of Urology , , San Francisco, School of Medicine, 400 Parnassus Ave #610, San Francisco, CA 94143 ,","place":["United States"]},{"name":"University of California , , San Francisco, School of Medicine, 400 Parnassus Ave #610, San Francisco, CA 94143 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A","family":"Kloner","sequence":"additional","affiliation":[{"name":"Chief Scientist and Director , , 686 S. Fair Oaks Ave., Pasadena, CA. 91105 ,","place":["United States"]},{"name":"Cardiovascular Research Institute, Huntington Medical Research Institutes , , 686 S. Fair Oaks Ave., Pasadena, CA. 91105 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"issue":"1","key":"2024100104312423800_ref1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","article-title":"Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study","volume":"151","author":"Feldman","year":"1994","journal-title":"J Urol"},{"issue":"2","key":"2024100104312423800_ref2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0022-5347(05)67900-1","article-title":"Incidence of erectile dysfunction in men 40 to 69 years of age: longitudinal results from the Massachusetts male aging study","volume":"163","author":"Johannes","year":"2000","journal-title":"J Urol"},{"issue":"4","key":"2024100104312423800_ref3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/pmed.2000.0643","article-title":"Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study","volume":"30","author":"Feldman","year":"2000","journal-title":"Prev Med"},{"issue":"2","key":"2024100104312423800_ref4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9149(00)00896-1","article-title":"Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton consensus panel","volume":"86","author":"DeBusk","year":"2000","journal-title":"Am J Cardiol"},{"issue":"2","key":"2024100104312423800_ref5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.amjcard.2005.03.065","article-title":"Sexual dysfunction and cardiac risk (the second Princeton consensus conference)","volume":"96","author":"Kostis","year":"2005","journal-title":"Am J Cardiol"},{"issue":"8","key":"2024100104312423800_ref6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.mayocp.2012.06.015","article-title":"The Princeton III consensus recommendations for the management of erectile dysfunction and cardiovascular disease","volume":"87","author":"Nehra","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"2024100104312423800_ref7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/jsxmed\/qdad163","article-title":"Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health","volume":"21","author":"Kloner","year":"2023","journal-title":"J Sex Med"},{"issue":"4","key":"2024100104312423800_ref8","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jama.295.4.440","article-title":"Theme issue on men's health","volume":"295","author":"Fontanarosa","year":"2006","journal-title":"JAMA"},{"issue":"10250","key":"2024100104312423800_ref9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","article-title":"Sex and gender: modifiers of health, disease, and medicine","volume":"396","author":"Mauvais-Jarvis","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"2024100104312423800_ref10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1557988313492171","article-title":"Integrating men's health and masculinity theories to explain colorectal cancer screening behavior","volume":"8","author":"Christy","year":"2014","journal-title":"Am J Mens Health"},{"key":"2024100104312423800_ref11","volume-title":"Health, United States, 2015: With Special Feature on Racial and Ethnic Health Disparities","author":"National Center for Health Statistics","year":"2016"},{"issue":"2","key":"2024100104312423800_ref12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jacc.2022.04.046","article-title":"Trends and disparities in cardiometabolic health among U.S. adults, 1999-2018","volume":"80","author":"O'Hearn","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2024100104312423800_ref13","first-page":"717","article-title":"Men's health: are we missing the big picture?","volume":"16","author":"Penson","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"9","key":"2024100104312423800_ref14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7748\/ns2000.11.15.9.47.c2943","article-title":"Men's health: a cause for concern","volume":"15","author":"Barton","year":"2000","journal-title":"Nurs Stand"},{"issue":"10","key":"2024100104312423800_ref15","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0277-9536(99)00390-1","article-title":"Constructions of masculinity and their influence on men's well-being: a theory of gender and health","volume":"50","author":"Courtenay","year":"2000","journal-title":"Soc Sci Med"},{"issue":"6","key":"2024100104312423800_ref16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0749-3797(18)31140-1","article-title":"Effects of sex on differences in awareness, treatment, and control of high blood pressure","volume":"4","author":"Plasencia","year":"1988","journal-title":"Am J Prev Med"},{"issue":"3","key":"2024100104312423800_ref17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2648.2000.01538.x","article-title":"The contexts of adherence for African Americans with high blood pressure","volume":"32","author":"Rose","year":"2000","journal-title":"J Adv Nurs"},{"key":"2024100104312423800_ref18","volume-title":"Out of Touch: American Men and the Health Care System: Commonwealth Fund men\u2019s and women\u2019s Health Survey Findings","author":"Sandman","year":"2000"},{"issue":"2","key":"2024100104312423800_ref19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4065\/84.2.108","article-title":"A population-based, longitudinal study of erectile dysfunction and future coronary artery disease","volume":"84","author":"Inman","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"23","key":"2024100104312423800_ref20","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1001\/jama.294.23.2996","article-title":"Erectile dysfunction and subsequent cardiovascular disease","volume":"294","author":"Thompson","year":"2005","journal-title":"JAMA"},{"issue":"11","key":"2024100104312423800_ref21","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"2024100104312423800_ref22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nrcardio.2013.216","article-title":"Risk factors: new risk-assessment guidelines\u2014more or less personalized?","volume":"11","author":"Blaha","year":"2014","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"2024100104312423800_ref23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.amjmed.2015.08.038","article-title":"Cardiovascular disease prevention in men with vascular erectile dysfunction: the view of the preventive cardiologist","volume":"129","author":"Shah","year":"2016","journal-title":"Am J Med"},{"issue":"8","key":"2024100104312423800_ref24","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.tcm.2019.01.002","article-title":"Erectile dysfunction links to cardiovascular disease-defining the clinical value","volume":"29","author":"Orimoloye","year":"2019","journal-title":"Trends Cardiovasc Med"},{"issue":"5","key":"2024100104312423800_ref25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/CIRCULATIONAHA.118.033990","article-title":"Erectile dysfunction as an independent predictor of future cardiovascular events: the multi-ethnic study of atherosclerosis","volume":"138","author":"Uddin","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"2024100104312423800_ref26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1358863X17725809","article-title":"The relationship of erectile dysfunction and subclinical cardiovascular disease: a systematic review and meta-analysis","volume":"23","author":"Osondu","year":"2018","journal-title":"Vasc Med"},{"issue":"5","key":"2024100104312423800_ref27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/clc.22530","article-title":"Subclinical vascular disease and subsequent erectile dysfunction: the multiethnic study of atherosclerosis (MESA)","volume":"39","author":"Feldman","year":"2016","journal-title":"Clin Cardiol"},{"issue":"4","key":"2024100104312423800_ref28","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jacc.2018.05.027","article-title":"Coronary calcium score and cardiovascular risk","volume":"72","author":"Greenland","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2024100104312423800_ref29","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2024100104312423800_ref30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.sxmr.2018.01.001","article-title":"Erectile dysfunction and subclinical cardiovascular disease","volume":"7","author":"Miner","year":"2019","journal-title":"Sex Med Rev"},{"issue":"13","key":"2024100104312423800_ref31","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jacc.2011.06.024","article-title":"Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies","volume":"58","author":"Dong","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2024100104312423800_ref32","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/CIRCULATIONAHA.109.864199","article-title":"Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: the ONgoing Telmisartan alone and in combination with Ramipril global endpoint trial\/Telmisartan randomized AssessmeNt study in ACE iNtolerant subjects with cardiovascular disease (ONTARGET\/TRANSCEND) trials","volume":"121","author":"B\u00f6hm","year":"2010","journal-title":"Circulation"},{"issue":"21","key":"2024100104312423800_ref33","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2007.10.069","article-title":"Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors","volume":"51","author":"Gazzaruso","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2024100104312423800_ref34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/sj.ijir.3901604","article-title":"Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: results from the Krimpen study","volume":"20","author":"Schouten","year":"2008","journal-title":"Int J Impot Res"},{"issue":"23","key":"2024100104312423800_ref35","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.jacc.2010.04.067","article-title":"Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (action in diabetes and vascular disease: Preterax and Diamicron modified-release controlled evaluation) trial","volume":"56","author":"Batty","year":"2010","journal-title":"J Am Coll Cardioly"},{"issue":"4","key":"2024100104312423800_ref36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.ijir.3901174","article-title":"Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study","volume":"16","author":"Blumentals","year":"2004","journal-title":"Int J Impot Res"},{"issue":"22","key":"2024100104312423800_ref37","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/eurheartj\/ehl142","article-title":"Association between erectile dysfunction and coronary artery disease: role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial","volume":"27","author":"Montorsi","year":"2006","journal-title":"Eur Heart J"},{"issue":"12","key":"2024100104312423800_ref38","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1111\/j.1742-1241.2007.01629.x","article-title":"The temporal relationship between erectile dysfunction and cardiovascular disease","volume":"61","author":"Hodges","year":"2007","journal-title":"Int J Clin Pract"},{"issue":"3","key":"2024100104312423800_ref39","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0302-2838(03)00305-1","article-title":"Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease","volume":"44","author":"Montorsi","year":"2003","journal-title":"Eur Urol"},{"issue":"3","key":"2024100104312423800_ref40","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.eururo.2005.05.014","article-title":"Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke?","volume":"48","author":"Ponholzer","year":"2005","journal-title":"Eur Urol"},{"issue":"2","key":"2024100104312423800_ref41","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2009.05.005","article-title":"The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing","volume":"207","author":"Polonsky","year":"2009","journal-title":"Atherosclerosis"},{"issue":"20","key":"2024100104312423800_ref42","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1001\/archinternmed.2011.440","article-title":"The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis","volume":"171","author":"Gupta","year":"2011","journal-title":"Arch Intern Med"},{"issue":"5","key":"2024100104312423800_ref43","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1743-6109.2011.02224.x","article-title":"Erectile dysfunction and coronary artery disease: an association of higher risk in younger men","volume":"8","author":"Riedner","year":"2011","journal-title":"J Sex Med"},{"issue":"3","key":"2024100104312423800_ref44","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1743-6109.2011.02591.x","article-title":"Evaluation of endothelial function with brachial artery ultrasound in men with or without erectile dysfunction and classified as intermediate risk according to the Framingham score","volume":"9","author":"Averbeck","year":"2012","journal-title":"J Sex Med"},{"issue":"11","key":"2024100104312423800_ref45","first-page":"Pc01","article-title":"Can erectile dysfunction in young patients serve as a surrogate marker for coronary artery disease?","volume":"9","author":"Dattatrya","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"6","key":"2024100104312423800_ref46","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/j.1743-6109.2009.01219.x","article-title":"Association of glycemic control with risk of erectile dysfunction in men with type 2 diabetes","volume":"6","author":"Lu","year":"2009","journal-title":"J Sex Med"},{"issue":"10","key":"2024100104312423800_ref47","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/j.1743-6109.2012.02869.x","article-title":"Is erectile dysfunction a reliable proxy of general male health status? The case for the international index of erectile function\u2014erectile function domain","volume":"9","author":"Salonia","year":"2012","journal-title":"J Sex Med"},{"key":"2024100104312423800_ref48","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.urology.2021.08.009","article-title":"Erectile dysfunction and treatment: an analysis of associated chronic health conditions","volume":"157","author":"Wright","year":"2021","journal-title":"Urology"},{"issue":"1_Part_1","key":"2024100104312423800_ref49","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1743-6109.2009.01576.x","article-title":"Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: findings from a linked-data study","volume":"7","author":"Chew","year":"2010","journal-title":"J Sex Med"},{"issue":"12","key":"2024100104312423800_ref50","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/ijcp.12908","article-title":"Relationship between age and erectile dysfunction diagnosis or treatment using real-world observational data in the USA","volume":"70","author":"Mulhall","year":"2016","journal-title":"Int J Clin Pract"},{"issue":"1","key":"2024100104312423800_ref51","doi-asserted-by":"crossref","first-page":"e1001372","DOI":"10.1371\/journal.pmed.1001372","article-title":"Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study","volume":"10","author":"Banks","year":"2013","journal-title":"PLoS Med"},{"issue":"2","key":"2024100104312423800_ref52","doi-asserted-by":"crossref","first-page":"724","DOI":"10.21037\/tau-20-1056","article-title":"Relationship between the risk factors of cardiovascular disease by testing biochemical markers and young men with erectile dysfunction: a case\u2013control study","volume":"10","author":"Ma","year":"2021","journal-title":"Transl Androl Urol"},{"issue":"4","key":"2024100104312423800_ref53","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1370\/afm.1816","article-title":"Erectile dysfunction and undiagnosed diabetes, hypertension, and hypercholesterolemia","volume":"13","author":"Skeldon","year":"2015","journal-title":"Ann Fam Med"},{"issue":"6","key":"2024100104312423800_ref54","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jsxm.2020.02.011","article-title":"Relation between severity of coronary artery disease and aorto-Ilio-pudendal artery disease in patients with ischemic heart disease\u2013associated vascular erectile dysfunction","volume":"17","author":"Sanad","year":"2020","journal-title":"J Sex Med"},{"issue":"7","key":"2024100104312423800_ref55","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/jsm.12175","article-title":"Erectile dysfunction, testosterone deficiency, and risk of coronary heart disease in a cohort of men living with HIV in Belgium","volume":"10","author":"De Ryck","year":"2013","journal-title":"J Sex Med"},{"issue":"4","key":"2024100104312423800_ref56","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1590\/S1677-5538.IBJU.2013.04.03","article-title":"Is there a relationship between severity of coronary artery disease and severity of erectile dysfunction?","volume":"39","author":"Canat","year":"2013","journal-title":"Int Braz J Urol"},{"issue":"4","key":"2024100104312423800_ref57","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/jsm.12052","article-title":"Impaired masturbation-induced erections: a new cardiovascular risk factor for male subjects with sexual dysfunction","volume":"10","author":"Rastrelli","year":"2013","journal-title":"J Sex Med"},{"issue":"8","key":"2024100104312423800_ref58","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.jsxm.2020.03.012","article-title":"Longitudinal risk of developing cardiovascular diseases in patients with erectile dysfunction: which patients deserve more attention?","volume":"17","author":"Pozzi","year":"2020","journal-title":"J Sex Med"},{"issue":"6","key":"2024100104312423800_ref59","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1177\/1557988317714359","article-title":"Erectile dysfunction in young myocardial infarction survivors: evaluation, follow up","volume":"11","author":"Dost\u00e1lov\u00e1","year":"2017","journal-title":"Am J Mens Health"},{"issue":"2","key":"2024100104312423800_ref60","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ihj.2020.03.007","article-title":"Concurrence of erectile dysfunction and coronary artery disease among patients undergoing coronary angiography at a tertiary medical College Hospital in Goa","volume":"72","author":"Desai","year":"2020","journal-title":"Indian Heart J"},{"key":"2024100104312423800_ref61","doi-asserted-by":"crossref","first-page":"708200","DOI":"10.3389\/fcvm.2021.708200","article-title":"Sexual dysfunction and the impact of beta-blockers in young males with coronary artery disease","volume":"8","author":"Dai","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"2024100104312423800_ref62","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/medicina49120080","article-title":"Association between erectile dysfunction and asymptomatic cardiovascular damage in middle-aged men","volume":"49","author":"D\u017eenkevi\u010di\u016bt\u0117","year":"2013","journal-title":"Medicina"},{"issue":"1","key":"2024100104312423800_ref63","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/andr.12561","article-title":"Penile Doppler ultrasound predicts cardiovascular events i n men with erectile dysfunction","volume":"7","author":"Caretta","year":"2019","journal-title":"Andrology"},{"issue":"4","key":"2024100104312423800_ref64","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00006842-199807000-00011","article-title":"The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts male aging study","volume":"60","author":"Araujo","year":"1998","journal-title":"Psychosom Med"},{"issue":"8","key":"2024100104312423800_ref65","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jsxm.2018.05.016","article-title":"Erectile dysfunction and depression: a systematic review and meta-analysis","volume":"15","author":"Liu","year":"2018","journal-title":"J Sex Med"},{"issue":"10","key":"2024100104312423800_ref66","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1111\/j.1743-6109.2010.01936.x","article-title":"Severe depressive symptoms and cardiovascular risk in subjects with erectile dysfunction","volume":"7","author":"Bandini","year":"2010","journal-title":"J Sex Med"},{"issue":"3","key":"2024100104312423800_ref67","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/jsm.12792","article-title":"Newly diagnosed erectile dysfunction and risk of depression: a population-based 5-year follow-up study in Taiwan","volume":"12","author":"Chou","year":"2015","journal-title":"J Sex Med"},{"issue":"3","key":"2024100104312423800_ref68","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1743-6109.2005.20354.x","article-title":"Relationships between erectile dysfunction, depression, and anxiety in Japanese subjects","volume":"2","author":"Sugimori","year":"2005","journal-title":"J Sex Med"},{"issue":"10","key":"2024100104312423800_ref69","doi-asserted-by":"crossref","first-page":"e13395","DOI":"10.1111\/and.13395","article-title":"Associations between erectile dysfunction and psychological disorders (depression and anxiety): a cross-sectional study in a Chinese population","volume":"51","author":"Yang","year":"2019","journal-title":"Andrologia"},{"issue":"2","key":"2024100104312423800_ref70","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.juro.2006.09.030","article-title":"Bidirectional relationship between depression and erectile dysfunction","volume":"177","author":"Shiri","year":"2007","journal-title":"J Urol"},{"issue":"2","key":"2024100104312423800_ref71","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jsxm.2021.11.011","article-title":"The temporal association of depression and anxiety in young men with erectile dysfunction","volume":"19","author":"Manalo","year":"2022","journal-title":"J Sex Med"},{"issue":"12","key":"2024100104312423800_ref72","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.jsxm.2021.09.016","article-title":"Erectile dysfunction is a modifiable risk factor for major depressive disorder: analysis of a federated research network","volume":"18","author":"Nackeeran","year":"2021","journal-title":"J Sex Med"},{"issue":"2","key":"2024100104312423800_ref73","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0090-4295(02)01691-6","article-title":"Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra) in treated and untreated patients with depression","volume":"60","author":"Nurnberg","year":"2002","journal-title":"Urology"},{"issue":"1","key":"2024100104312423800_ref74","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1176\/appi.ajp.163.1.79","article-title":"Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study","volume":"163","author":"Rosen","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"2","key":"2024100104312423800_ref75","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/jsm.12374","article-title":"A systematic review of the psychosocial outcomes associated with erectile dysfunction: does the impact of erectile dysfunction extend beyond a man's inability to have sex?","volume":"11","author":"McCabe","year":"2014","journal-title":"J Sex Med"},{"issue":"6","key":"2024100104312423800_ref76","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/j.1743-6109.2012.02709.x","article-title":"Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis","volume":"9","author":"Atlantis","year":"2012","journal-title":"J Sex Med"},{"issue":"3","key":"2024100104312423800_ref77","first-page":"182","article-title":"Female sexual dysfunction related to depression and antidepressant medications","volume":"2","author":"Clayton","year":"2002","journal-title":"Curr Womens Health Rep"},{"issue":"3","key":"2024100104312423800_ref78","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/PSY.0b013e31824c4c89","article-title":"Depression in premenopausal women with HSDD: baseline findings from the HSDD registry for women","volume":"74","author":"Clayton","year":"2012","journal-title":"Psychosom Med"},{"issue":"2","key":"2024100104312423800_ref79","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/1573403X15666191127104520","article-title":"Depression related pathophysiologies relevant in heart disease: insights into the mechanism based on pharmacological treatments","volume":"16","author":"Varghese","year":"2020","journal-title":"Curr Cardiol Rev"},{"issue":"2","key":"2024100104312423800_ref80","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1192\/bjp.2019.130","article-title":"An attempt to explain the bidirectional association between ischaemic heart disease, stroke and depression: a cohort and meta-analytic approach","volume":"217","author":"Wium-Andersen","year":"2020","journal-title":"Br J Psychiatry"},{"issue":"7","key":"2024100104312423800_ref81","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41380-019-0395-3","article-title":"Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort","volume":"25","author":"Khandaker","year":"2020","journal-title":"Mol Psychiatry"},{"key":"2024100104312423800_ref82","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijcard.2022.05.056","article-title":"Depression and ischemic heart disease","volume":"364","author":"Pivato","year":"2022","journal-title":"Int J Cardiol"},{"issue":"22","key":"2024100104312423800_ref83","doi-asserted-by":"crossref","first-page":"e018686","DOI":"10.1161\/JAHA.120.018686","article-title":"Psychiatric and psychological interventions for depression in patients with heart disease: a scoping review","volume":"9","author":"Zambrano","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"2024100104312423800_ref84","doi-asserted-by":"crossref","first-page":"e13078","DOI":"10.1111\/ijcp.13078","article-title":"Real-world observational results from a database of 48 million men in the United States: relationship of cardiovascular disease, diabetes mellitus and depression with age and erectile dysfunction","volume":"72","author":"Goldstein","year":"2018","journal-title":"Int J Clin Pract"},{"issue":"3","key":"2024100104312423800_ref85","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11920-996-0008-0","article-title":"The relationship between depression and erectile dysfunction","volume":"2","author":"Seidman","year":"2000","journal-title":"Curr Psychiatry Rep"},{"key":"2024100104312423800_ref86","volume-title":"Human Sexual Inadequacy","author":"Masters","year":"1970"},{"issue":"2","key":"2024100104312423800_ref87","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0094-0143(05)70137-3","article-title":"Psychogenic erectile dysfunction. Classification and management","volume":"28","author":"Rosen","year":"2001","journal-title":"Urol Clin North Am"},{"issue":"2","key":"2024100104312423800_ref88","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/00926239408403419","article-title":"Psychologically based treatment for male erectile disorder: a cognitive-interpersonal model","volume":"20","author":"Rosen","year":"1994","journal-title":"J Sex Marital Ther"},{"issue":"10","key":"2024100104312423800_ref89","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1111\/j.1743-6109.2011.02391.x","article-title":"A randomized controlled trial of guided internet-delivered cognitive behavioral therapy for erectile dysfunction","volume":"8","author":"Andersson","year":"2011","journal-title":"J Sex Med"},{"key":"2024100104312423800_ref90","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.esxm.2020.05.005","article-title":"Cognitive behavioral sex therapy: an emerging treatment option for nonorganic erectile dysfunction in young men: a feasibility pilot study","volume":"8","author":"Bilal","year":"2020","journal-title":"Sex Med"},{"issue":"10","key":"2024100104312423800_ref91","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jsxm.2018.08.013","article-title":"Mindfulness-based group therapy for men with situational erectile dysfunction: a mixed-methods feasibility analysis and pilot study","volume":"15","author":"Bossio","year":"2018","journal-title":"J Sex Med"},{"issue":"2","key":"2024100104312423800_ref92","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jsxm.2018.12.014","article-title":"Potential for long-term benefit of cognitive behavioral therapy as an adjunct treatment for men with erectile dysfunction","volume":"16","author":"Khan","year":"2019","journal-title":"J Sex Med"},{"issue":"2","key":"2024100104312423800_ref93","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ucl.2011.03.004","article-title":"Erectile dysfunction and depression: screening and treatment","volume":"38","author":"Perelman","year":"2011","journal-title":"Urol Clin North Am"},{"issue":"2","key":"2024100104312423800_ref94","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1743-6109.2004.04023.x","article-title":"The multinational Men's attitudes to life events and sexuality (MALES) study phase II: understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction","volume":"1","author":"Fisher","year":"2004","journal-title":"J Sex Med"},{"issue":"3","key":"2024100104312423800_ref95","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/jsxmed\/qdac042","article-title":"Role of psychosexual counseling as an adjuvant to pharmacotherapy in the treatment of erectile dysfunction","volume":"20","author":"Althof","year":"2023","journal-title":"J Sex Med"},{"issue":"3","key":"2024100104312423800_ref96","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ijir.2013.41","article-title":"Reasons and predictive factors for discontinuation of PDE-5 inhibitors despite successful intercourse in erectile dysfunction patients","volume":"26","author":"Kim","year":"2014","journal-title":"Int J Impot Res"},{"issue":"1","key":"2024100104312423800_ref97","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2164\/jandrol.107.003483","article-title":"Molecular pharmacotherapeutic targeting of PDE5 for preservation of penile health","volume":"29","author":"Burnett","year":"2008","journal-title":"J Androl"},{"issue":"20","key":"2024100104312423800_ref98","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1074\/jbc.274.20.13729","article-title":"Cyclic GMP phosphodiesterase-5: target of sildenafil","volume":"274","author":"Corbin","year":"1999","journal-title":"J Biol Chem"},{"key":"2024100104312423800_ref99","doi-asserted-by":"crossref","first-page":"627229","DOI":"10.3389\/fonc.2021.627229","article-title":"New approaches in oncology for repositioning drugs: the case of PDE5 inhibitor sildenafil","volume":"11","author":"Cruz-Burgos","year":"2021","journal-title":"Front Oncol"},{"issue":"12","key":"2024100104312423800_ref100","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00210-017-1429-5","article-title":"Meeting report of the 8th international conference on cGMP \"cGMP: generators, effectors, and therapeutic implications\" at Bamberg, Germany, from June 23 to 25, 2017","volume":"390","author":"Friebe","year":"2017","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"issue":"4","key":"2024100104312423800_ref101","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1743-6109.2006.00270.x","article-title":"Nitric oxide in the penis: science and therapeutic implications from erectile dysfunction to priapism","volume":"3","author":"Burnett","year":"2006","journal-title":"J Sex Med"},{"issue":"2","key":"2024100104312423800_ref102","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/JU.0000000000001365","article-title":"Regimented phosphodiesterase type 5 inhibitor use reduces emergency department visits for recurrent ischemic priapism","volume":"205","author":"Hou","year":"2021","journal-title":"J Urol"},{"issue":"49","key":"2024100104312423800_ref103","doi-asserted-by":"crossref","first-page":"47581","DOI":"10.1074\/jbc.M206088200","article-title":"Phosphorylation of isolated human phosphodiesterase-5 regulatory domain induces an apparent conformational change and increases cGMP binding affinity","volume":"277","author":"Francis","year":"2002","journal-title":"J Biol Chem"},{"issue":"12","key":"2024100104312423800_ref104","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jama.2011.336","article-title":"Association of episodic physical and sexual activity with triggering of acute cardiac events: systematic review and meta-analysis","volume":"305","author":"Dahabreh","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"2024100104312423800_ref105","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.juro.2018.05.004","article-title":"Erectile dysfunction: AUA guideline","volume":"200","author":"Burnett","year":"2018","journal-title":"J Urol"},{"issue":"2","key":"2024100104312423800_ref106","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/WNO.0000000000000299","article-title":"The relationship between Phosphodiesterase-5 inhibitors and Nonarteritic anterior ischemic optic neuropathy","volume":"36","author":"Pomeranz","year":"2016","journal-title":"J Neuroophthalmol"},{"issue":"5","key":"2024100104312423800_ref107","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/jamaophthalmol.2022.0663","article-title":"Risk of ocular adverse events associated with use of phosphodiesterase 5 inhibitors in men in the US","volume":"140","author":"Etminan","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"13","key":"2024100104312423800_ref108","first-page":"3058","article-title":"3\u2032,5\u2032-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition","volume":"53","author":"Drees","year":"1993","journal-title":"Cancer Res"},{"issue":"6","key":"2024100104312423800_ref109","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jamainternmed.2014.594","article-title":"Sildenafil use and increased risk of incident melanoma in US men: a prospective cohort study","volume":"174","author":"Li","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"4","key":"2024100104312423800_ref110","doi-asserted-by":"crossref","first-page":"e13849","DOI":"10.1111\/ijcp.13849","article-title":"Increasing access to erectile dysfunction treatment via pharmacies to improve healthcare provider visits and quality of life: results from a prospective real-world observational study in the United Kingdom","volume":"75","author":"Lee","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"24","key":"2024100104312423800_ref111","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1001\/jama.291.24.2978","article-title":"Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial","volume":"291","author":"Esposito","year":"2004","journal-title":"JAMA"},{"issue":"16","key":"2024100104312423800_ref112","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1056\/NEJMsa1504267","article-title":"Emergency department visits for adverse events related to dietary supplements","volume":"373","author":"Geller","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"2024100104312423800_ref113","doi-asserted-by":"crossref","first-page":"e183337","DOI":"10.1001\/jamanetworkopen.2018.3337","article-title":"Unapproved pharmaceutical ingredients included in dietary supplements associated with US Food and Drug Administration warnings","volume":"1","author":"Tucker","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"2","key":"2024100104312423800_ref114","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/01.ju.0000165187.31941.cd","article-title":"Evidence for contamination of herbal erectile dysfunction products with phosphodiesterase type 5 inhibitors","volume":"174","author":"Fleshner","year":"2005","journal-title":"J Urol"},{"issue":"7","key":"2024100104312423800_ref115","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/jsm.12172","article-title":"Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors","volume":"10","author":"Campbell","year":"2013","journal-title":"J Sex Med"},{"issue":"4","key":"2024100104312423800_ref116","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2125.2009.03375.x","article-title":"Time-dependent interactions of the hypotensive effects of sildenafil citrate and sublingual glyceryl trinitrate","volume":"67","author":"Oliver","year":"2009","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2024100104312423800_ref117","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0735-1097(98)00656-1","article-title":"ACC\/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology\/American Heart Association","volume":"33","author":"Cheitlin","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2024100104312423800_ref118","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.jacc.2003.09.023","article-title":"Time course of the interaction between tadalafil and nitrates","volume":"42","author":"Kloner","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"2024100104312423800_ref119","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1097\/01.CCM.0000269371.70738.30","article-title":"Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial","volume":"35","author":"Parker","year":"2007","journal-title":"Crit Care Med"},{"key":"2024100104312423800_ref120","first-page":"212-248","article-title":"Hemodynamic effect of avanafil and glyceryl trinitrate coadministration","volume":"2013","author":"Swearingen","year":"2013","journal-title":"Drugs Context"},{"issue":"5A","key":"2024100104312423800_ref121","doi-asserted-by":"crossref","first-page":"21C","DOI":"10.1016\/S0002-9149(99)00044-2","article-title":"Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist","volume":"83","author":"Webb","year":"1999","journal-title":"Am J Cardiol"},{"issue":"1","key":"2024100104312423800_ref122","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0735-1097(00)00705-1","article-title":"Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina","volume":"36","author":"Webb","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2024100104312423800_ref123","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/1074248418771896","article-title":"A new perspective on the nitrate-phosphodiesterase type 5 inhibitor interaction","volume":"23","author":"Kloner","year":"2018","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"6","key":"2024100104312423800_ref124","doi-asserted-by":"crossref","first-page":"774","DOI":"10.7326\/M21-3445","article-title":"Adverse events associated with coprescription of phosphodiesterase type 5 inhibitors and oral organic nitrates in male patients with ischemic heart disease : a case-crossover study","volume":"175","author":"Holt","year":"2022","journal-title":"Ann Intern Med"},{"issue":"9","key":"2024100104312423800_ref125","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.jsxm.2021.06.010","article-title":"Cardiovascular outcome risks in patients with erectile dysfunction Co-prescribed a phosphodiesterase type 5 inhibitor (PDE5i) and a nitrate: a retrospective observational study using electronic health record data in the United States","volume":"18","author":"Nunes","year":"2021","journal-title":"J Sex Med"},{"issue":"2","key":"2024100104312423800_ref126","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.eururo.2004.10.002","article-title":"Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk","volume":"47","author":"Rosano","year":"2005","journal-title":"Eur Urol"},{"issue":"21","key":"2024100104312423800_ref127","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1136\/heartjnl-2015-309223","article-title":"Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality","volume":"102","author":"Anderson","year":"2016","journal-title":"Heart"},{"issue":"16","key":"2024100104312423800_ref128","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/heartjnl-2016-310746","article-title":"Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction","volume":"103","author":"Andersson","year":"2017","journal-title":"Heart"},{"issue":"3","key":"2024100104312423800_ref129","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4239\/wjd.v8.i3.104","article-title":"Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes","volume":"8","author":"Hackett","year":"2017","journal-title":"World J Diabetes"},{"issue":"12","key":"2024100104312423800_ref130","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.jacc.2021.01.045","article-title":"Association of phosphodiesterase-5 inhibitors versus alprostadil with survival in men with coronary artery disease","volume":"77","author":"Andersson","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"2024100104312423800_ref131","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1177\/2047487317718082","article-title":"Relationship between treatment of erectile dysfunction and future risk of cardiovascular disease: a nationwide cohort study","volume":"24","author":"Vestergaard","year":"2017","journal-title":"Eur J Prev Cardiol"},{"issue":"7","key":"2024100104312423800_ref132","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s00345-022-04005-3","article-title":"Is tadalafil associated with decreased risk 3of major adverse cardiac events or venous thromboembolism in men with lower urinary tract symptoms?","volume":"40","author":"Goberdhan","year":"2022","journal-title":"World J Urol"},{"issue":"1","key":"2024100104312423800_ref133","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/jsxmed\/qdac005","article-title":"Effect of phosphodiesterase type 5 inhibitors on major adverse cardiovascular events and overall mortality in a large nationwide cohort of men with erectile dysfunction and cardiovascular risk factors: a retrospective, observational study based on healthcare claims and national death index data","volume":"20","author":"Kloner","year":"2023","journal-title":"J Sex Med"},{"issue":"1","key":"2024100104312423800_ref134","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.ijir.3901497","article-title":"The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size","volume":"19","author":"Sesti","year":"2007","journal-title":"Int J Impot Res"},{"issue":"20","key":"2024100104312423800_ref135","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","article-title":"Oral sildenafil in the treatment of erectile dysfunction. Sildenafil study group","volume":"338","author":"Goldstein","year":"1998","journal-title":"N Engl J Med"},{"issue":"8","key":"2024100104312423800_ref136","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41443-021-00456-1","article-title":"The use of combination regenerative therapies for erectile dysfunction: rationale and current status","volume":"34","author":"Towe","year":"2022","journal-title":"Int J Impot Res"},{"issue":"8","key":"2024100104312423800_ref137","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41443-022-00602-3","article-title":"News and future perspectives of non-surgical treatments for erectile dysfunction","volume":"35","author":"Manfredi","year":"2022","journal-title":"Int J Impot Res"},{"issue":"1","key":"2024100104312423800_ref138","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/aja.2011.79","article-title":"Stem cells: novel players in the treatment of erectile dysfunction","volume":"14","author":"Zhang","year":"2012","journal-title":"Asian journal of andrology"},{"issue":"2","key":"2024100104312423800_ref139","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.47391\/JPMA.AKUS-11","article-title":"Stem cells in urology","volume":"73","author":"Nazim","year":"2023","journal-title":"J Pak Med Assoc"},{"issue":"4","key":"2024100104312423800_ref140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41443-021-00482-z","article-title":"The potential of platelet-rich plasma injections and stem cell therapy for penile rejuvenation","volume":"34","author":"Israeli","year":"2022","journal-title":"Int J Impot Res"},{"key":"2024100104312423800_ref141","doi-asserted-by":"crossref","first-page":"944765","DOI":"10.3389\/frph.2022.944765","article-title":"Erectile dysfunction: is platelet-rich plasma the new frontier for treatment in patients with erectile dysfunction? A review of the existing evidence","volume":"4","author":"Anastasiadis","year":"2022","journal-title":"Front Reprod Health"},{"issue":"20","key":"2024100104312423800_ref142","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207794","article-title":"Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020","volume":"21","author":"Everts","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2024100104312423800_ref143","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.eururo.2016.05.050","article-title":"Low-intensity extracorporeal shock wave treatment improves erectile function: a systematic review and meta-analysis","volume":"71","author":"Lu","year":"2017","journal-title":"Eur Urol"},{"issue":"2","key":"2024100104312423800_ref144","doi-asserted-by":"crossref","first-page":"155798832210875","DOI":"10.1177\/15579883221087532","article-title":"Systematic review and meta-analysis of 16 randomized controlled trials of clinical outcomes of low-intensity extracorporeal shock wave therapy in treating erectile dysfunction","volume":"16","author":"Yao","year":"2022","journal-title":"Am J Mens Health"},{"issue":"6","key":"2024100104312423800_ref145","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/ijir.2011.38","article-title":"Tracking intracavernously injected adipose-derived stem cells to bone marrow","volume":"23","author":"Lin","year":"2011","journal-title":"Int J Impot Res"},{"issue":"6","key":"2024100104312423800_ref146","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/14712598.2023.2203811","article-title":"Recent advances in stem cell therapy for erectile dysfunction: a narrative review","volume":"23","author":"Wang","year":"2023","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"2024100104312423800_ref147","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.sxmr.2019.08.003","article-title":"A systematic review of human trials using stem cell therapy for erectile dysfunction","volume":"8","author":"Lokeshwar","year":"2020","journal-title":"Sex Med Rev"},{"issue":"4","key":"2024100104312423800_ref148","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jsxm.2020.01.003","article-title":"The effect of transendocardial stem cell injection on erectile function in men with cardiomyopathy: results from the TRIDENT, POSEIDON, and TAC-HFT trials","volume":"17","author":"Ory","year":"2020","journal-title":"J Sex Med"},{"issue":"2","key":"2024100104312423800_ref149","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2010.04.004","article-title":"Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction","volume":"58","author":"Vardi","year":"2010","journal-title":"Eur Urol"},{"issue":"10","key":"2024100104312423800_ref150","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrurol.2017.119","article-title":"Low-intensity shockwave therapy for erectile dysfunction: is the evidence strong enough?","volume":"14","author":"Young Academic Urologists Men's Health Group","year":"2017","journal-title":"Nat Rev Urol"},{"issue":"1","key":"2024100104312423800_ref151","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jsxm.2015.11.008","article-title":"Low-energy shock wave therapy ameliorates erectile dysfunction in a pelvic neurovascular injuries rat model","volume":"13","author":"Li","year":"2016","journal-title":"J Sex Med"},{"issue":"4","key":"2024100104312423800_ref152","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jsxm.2017.02.004","article-title":"In situ activation of penile progenitor cells with low-intensity extracorporeal shockwave therapy","volume":"14","author":"Lin","year":"2017","journal-title":"J Sex Med"},{"issue":"9","key":"2024100104312423800_ref153","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.jsxm.2020.05.018","article-title":"Exosome released from schwann cells may be involved in microenergy acoustic pulse-associated cavernous nerve regeneration","volume":"17","author":"Peng","year":"2020","journal-title":"J Sex Med"},{"issue":"12","key":"2024100104312423800_ref154","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.jsxm.2019.08.020","article-title":"Smooth muscle differentiation of penile stem\/progenitor cells induced by microenergy acoustic pulses in vitro","volume":"16","author":"Peng","year":"2019","journal-title":"J Sex Med"},{"issue":"10","key":"2024100104312423800_ref155","doi-asserted-by":"crossref","first-page":"e14197","DOI":"10.1111\/and.14197","article-title":"Comparison of the efficacy of low-intensity shock wave therapy and its combination with platelet-rich plasma in patients with erectile dysfunction","volume":"53","author":"Geyik","year":"2021","journal-title":"Andrologia"},{"issue":"3","key":"2024100104312423800_ref156","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41443-019-0115-1","article-title":"Clinical trial update on shockwave therapy and future of erectile function restoration","volume":"31","author":"Patel","year":"2019","journal-title":"Int J Impot Res"},{"issue":"6","key":"2024100104312423800_ref157","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.21037\/tau-21-79","article-title":"Extracorporeal shock wave therapy combined with engineered mesenchymal stem cells expressing stromal cell-derived factor-1 can improve erectile dysfunction in streptozotocin-induced diabetic rats","volume":"10","author":"Shin","year":"2021","journal-title":"Transl Androl Urol"},{"issue":"2","key":"2024100104312423800_ref158","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.ijir.3900411","article-title":"The Process of Care Model for evaluation and treatment of erectile dysfunction. The Process of Care Consensus Panel","volume":"11","year":"1999","journal-title":"Int J Impot Res"},{"key":"2024100104312423800_ref159","first-page":"S28","article-title":"Optimizing outcomes of oral therapy for patients with erectile dysfunction","volume":"5","author":"Barada","year":"2003","journal-title":"Rev Urol"},{"issue":"1","key":"2024100104312423800_ref160","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/sj.ijir.3901143","article-title":"Rechallenge prior sildenafil nonresponders","volume":"16","author":"Jiann","year":"2004","journal-title":"Int J Impot Res"},{"issue":"2","key":"2024100104312423800_ref161","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0094-0143(05)70142-7","article-title":"Vacuum constriction and external erection devices in erectile dysfunction","volume":"28","author":"Levine","year":"2001","journal-title":"Urol Clin North Am"},{"issue":"2","key":"2024100104312423800_ref162","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41585-021-00532-7","article-title":"Indications and characteristics of penile traction and vacuum erection devices","volume":"19","author":"Sultana","year":"2022","journal-title":"Nat Rev Urol"},{"issue":"17","key":"2024100104312423800_ref163","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.2165\/11641380-000000000-00000","article-title":"Intraurethral alprostadil for erectile dysfunction: a review of the literature","volume":"72","author":"Costa","year":"2012","journal-title":"Drugs"},{"issue":"6","key":"2024100104312423800_ref164","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2164\/jandrol.05035","article-title":"Combination therapy: medicated urethral system for erection enhances sexual satisfaction in sildenafil citrate failure following nerve-sparing radical prostatectomy","volume":"26","author":"Raina","year":"2005","journal-title":"J Androl"},{"issue":"S1","key":"2024100104312423800_ref165","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1038\/sj.ijir.3900795","article-title":"Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy","volume":"14","author":"Nehra","year":"2002","journal-title":"Int J Impot Res"},{"issue":"1","key":"2024100104312423800_ref166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199701023360101","article-title":"Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated urethral system for erection (MUSE) study group","volume":"336","author":"Padma-Nathan","year":"1997","journal-title":"N Engl J Med"},{"issue":"4","key":"2024100104312423800_ref167","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1192\/bjp.143.4.332","article-title":"Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence","volume":"143","author":"Brindley","year":"1983","journal-title":"Br J Psychiatry"},{"issue":"8304","key":"2024100104312423800_ref168","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(82)90910-2","article-title":"Intracavernous injection of papaverine for erectile failure","volume":"2","author":"Virag","year":"1982","journal-title":"Lancet"},{"issue":"3","key":"2024100104312423800_ref169","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/BF00326824","article-title":"Intracavernosal pharmacotherapy: the pharmacologic erection program","volume":"5","author":"Padma-Nathan","year":"1987","journal-title":"World J Urol"},{"issue":"5","key":"2024100104312423800_ref170","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/S0022-5347(01)64118-1","article-title":"Intracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapy","volume":"158","author":"Mulhall","year":"1997","journal-title":"J Urol"},{"issue":"5","key":"2024100104312423800_ref171","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1464-410X.2008.07738.x","article-title":"Intracavernosal injections and fibrosis: myth or reality?","volume":"102","author":"Tal","year":"2008","journal-title":"BJU Int"},{"issue":"4","key":"2024100104312423800_ref172","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0022-5347(05)68269-9","article-title":"The causes of patient dropout from penile self-injection therapy for impotence","volume":"162","author":"Mulhall","year":"1999","journal-title":"J Urol"},{"issue":"1","key":"2024100104312423800_ref173","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000020248","article-title":"Initial results utilizing combination therapy for patients with a suboptimal response to either alprostadil or sildenafil monotherapy","volume":"38","author":"Mydlo","year":"2000","journal-title":"Eur Urol"},{"issue":"12","key":"2024100104312423800_ref174","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.jsxm.2016.09.020","article-title":"Toward a more evidence-based nosology and nomenclature for female sexual dysfunctions\u2014part II","volume":"13","author":"Parish","year":"2016","journal-title":"J Sex Med"},{"issue":"1","key":"2024100104312423800_ref175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00005392-199707000-00020","article-title":"Immunohistochemical description of nitric oxide synthase isoforms in human clitoris","volume":"158","author":"Burnett","year":"1997","journal-title":"J Urol"},{"issue":"Pt 3","key":"2024100104312423800_ref176","first-page":"633","article-title":"Innervation of vasculature and microvasculature of the human vagina by NOS and neuropeptide-containing nerves","volume":"188","author":"Hoyle","year":"1996","journal-title":"J Anat"},{"issue":"1","key":"2024100104312423800_ref177","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0090-4295(02)01663-1","article-title":"Type 5 phosphodiesterase expression in the human vagina","volume":"60","author":"D'Amati","year":"2002","journal-title":"Urology"},{"issue":"3","key":"2024100104312423800_ref178","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.urology.2004.10.028","article-title":"Cyclic adenosine monophosphate and cyclic guanosine monophosphate-phosphodiesterase isoenzymes in human vagina: relation to nitric oxide synthase isoforms and vasoactive intestinal polypeptide-containing nerves","volume":"65","author":"Uckert","year":"2005","journal-title":"Urology"},{"issue":"8","key":"2024100104312423800_ref179","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/sj.bjp.0702278","article-title":"Nitrergic neurotransmission mediates the non-adrenergic non-cholinergic responses in the clitoral corpus cavernosum of the rabbit","volume":"125","author":"Cellek","year":"1998","journal-title":"Br J Pharmacol"},{"issue":"4","key":"2024100104312423800_ref180","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ijir.3901162","article-title":"Functional evidence for nitrergic neurotransmission in a human clitoral corpus cavernosum: a case study","volume":"16","author":"Creighton","year":"2004","journal-title":"Int J Impot Res"},{"issue":"1","key":"2024100104312423800_ref181","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.ijir.3900258","article-title":"Vasculogenic female sexual dysfunction: the hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency","volume":"9","author":"Park","year":"1997","journal-title":"Int J Impot Res"},{"issue":"5","key":"2024100104312423800_ref182","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.ijir.3901038","article-title":"Role of the nitric oxide-cyclic GMP pathway in regulation of vaginal blood flow","volume":"15","author":"Kim","year":"2003","journal-title":"Int J Impot Res"},{"issue":"3","key":"2024100104312423800_ref183","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/01.ju.0000109868.19569.d7","article-title":"An in vivo rat model to investigate female vaginal arousal response","volume":"171","author":"Kim","year":"2004","journal-title":"J Urol"},{"issue":"2 Pt 2","key":"2024100104312423800_ref184","first-page":"S40","article-title":"A review of the physiology and pharmacology of peripheral (vaginal and clitoral) female genital arousal in the animal model","volume":"170","author":"Munarriz","year":"2003","journal-title":"J Urol"},{"issue":"9","key":"2024100104312423800_ref185","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1111\/j.1743-6109.2010.01903.x","article-title":"Biochemical factors modulating female genital sexual arousal physiology","volume":"7","author":"Traish","year":"2010","journal-title":"J Sex Med"},{"issue":"3","key":"2024100104312423800_ref186","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jsxm.2021.12.009","article-title":"Cardiometabolic diseases and female sexual dysfunction: animal studies","volume":"19","author":"Angulo","year":"2022","journal-title":"J Sex Med"},{"issue":"7-8","key":"2024100104312423800_ref187","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1345\/aph.1L691","article-title":"Assessing the clinical efficacy of sildenafil for the treatment of female sexual dysfunction","volume":"43","author":"Brown","year":"2009","journal-title":"Ann Pharmacother"},{"issue":"Supplement_3","key":"2024100104312423800_ref188","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1016\/j.jsxm.2020.04.258","article-title":"Preliminary efficacy of sildenafil cream, 3.6% during female sexual arousal","volume":"17","author":"Goldstein","year":"2020","journal-title":"J Sex Med"},{"issue":"2","key":"2024100104312423800_ref189","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1743-6109.2010.02045.x","article-title":"Vascular modifications of the clitoris induced by topic nitric oxide donor gel\u2014preliminary study","volume":"8","author":"Souto","year":"2011","journal-title":"J Sex Med"},{"issue":"23-24","key":"2024100104312423800_ref190","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1016\/j.biomaterials.2009.04.004","article-title":"In vivo evaluation of vaginal films for mucosal delivery of nitric oxide","volume":"30","author":"Yoo","year":"2009","journal-title":"Biomaterials"},{"issue":"6","key":"2024100104312423800_ref191","doi-asserted-by":"crossref","first-page":"100570","DOI":"10.1016\/j.esxm.2022.100570","article-title":"Effects of flibanserin on subdomain scores of the female sexual function index in women with hypoactive sexual desire disorder","volume":"10","author":"Simon","year":"2022","journal-title":"Sex Med"},{"issue":"12","key":"2024100104312423800_ref192","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1096\/fj.04-1978com","article-title":"The neurovascular mechanism of clitoral erection: nitric oxide and cGMP-stimulated activation of BKCa channels","volume":"18","author":"Gragasin","year":"2004","journal-title":"FASEB J"},{"issue":"2","key":"2024100104312423800_ref193","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijgo.2015.08.015","article-title":"Systematic review and meta-analysis of phosphodiesterase type 5 inhibitors for the treatment of female sexual dysfunction","volume":"133","author":"Gao","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"2024100104312423800_ref194","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0090-4295(00)00493-3","article-title":"Sildenafil effects on sexual and cardiovascular responses in women with spinal cord injury","volume":"55","author":"Sipski","year":"2000","journal-title":"Urology"},{"issue":"6","key":"2024100104312423800_ref195","first-page":"623","article-title":"Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study","volume":"108","author":"Caruso","year":"2001","journal-title":"BJOG"},{"issue":"4","key":"2024100104312423800_ref196","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jama.300.4.395","article-title":"Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial","volume":"300","author":"Nurnberg","year":"2008","journal-title":"JAMA"},{"issue":"4","key":"2024100104312423800_ref197","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/152460902317586001","article-title":"Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder","volume":"11","author":"Basson","year":"2002","journal-title":"J Womens Health Gend Based Med"},{"issue":"3","key":"2024100104312423800_ref198","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0090-4295(98)00633-5","article-title":"Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction","volume":"53","author":"Kaplan","year":"1999","journal-title":"Urology"},{"issue":"2","key":"2024100104312423800_ref199","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0301-2115(03)00118-0","article-title":"The function of sildenafil on female sexual pathways: a double-blind, cross-over, placebo-controlled study","volume":"110","author":"Caruso","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"11","key":"2024100104312423800_ref200","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1471-0528.2003.02438.x","article-title":"Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial","volume":"110","author":"Basson","year":"2003","journal-title":"BJOG"},{"issue":"6","key":"2024100104312423800_ref201","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00345-005-0015-5","article-title":"Phosphodiesterase inhibitors in female sexual dysfunction","volume":"23","author":"Mayer","year":"2005","journal-title":"World J Urol"},{"key":"2024100104312423800_ref202","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/10532528.2002.10559802","article-title":"PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes","volume":"13","author":"Rosen","year":"2002","journal-title":"Annu Rev Sex Res"},{"issue":"2_Part_2","key":"2024100104312423800_ref203","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1743-6109.2009.01599.x","article-title":"Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms?","volume":"7","author":"Chivers","year":"2010","journal-title":"J Sex Med"},{"issue":"Suppl 4","key":"2024100104312423800_ref204","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0015-0282(02)02978-3","article-title":"Role of androgens in female genital sexual arousal: receptor expression, structure, and function","volume":"77","author":"Traish","year":"2002","journal-title":"Fertil Steril"},{"issue":"4","key":"2024100104312423800_ref205","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.sxmr.2018.03.005","article-title":"Role of androgens in female genitourinary tissue structure and function: implications in the genitourinary syndrome of menopause","volume":"6","author":"Traish","year":"2018","journal-title":"Sex Med Rev"},{"issue":"3","key":"2024100104312423800_ref206","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1743-6109.2008.01142.x","article-title":"The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction","volume":"6","author":"van der Made","year":"2009","journal-title":"J Sex Med"},{"issue":"5","key":"2024100104312423800_ref207","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.mayocp.2019.01.009","article-title":"The International Society for the Study of Women's sexual health process of care for the identification of sexual concerns and problems in women","volume":"94","author":"Parish","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"2024100104312423800_ref208","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.mayocp.2017.11.002","article-title":"The International Society for the Study of Women's sexual health process of care for management of hypoactive sexual desire disorder in women","volume":"93","author":"Clayton","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"2024100104312423800_ref209","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jsxm.2021.01.172","article-title":"International Society for the Study of Women's sexual health (ISSWSH) review of epidemiology and pathophysiology, and a consensus nomenclature and process of care for the management of persistent genital arousal disorder\/genito-pelvic dysesthesia (PGAD\/GPD)","volume":"18","author":"Goldstein","year":"2021","journal-title":"J Sex Med"},{"issue":"9","key":"2024100104312423800_ref210","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.jsxm.2019.07.012","article-title":"Global consensus position statement on the use of testosterone therapy for women","volume":"16","author":"Davis","year":"2019","journal-title":"J Sex Med"},{"issue":"5","key":"2024100104312423800_ref211","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jsxm.2020.10.009","article-title":"International Society for the Study of Women's sexual health clinical practice guideline for the use of systemic testosterone for hypoactive sexual desire disorder in women","volume":"18","author":"Parish","year":"2021","journal-title":"J Sex Med"},{"issue":"6","key":"2024100104312423800_ref212","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/GME.0000000000001121","article-title":"Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from the North American Menopause Society and the International Society for the Study of Women's sexual health","volume":"25","author":"Faubion","year":"2018","journal-title":"Menopause"},{"issue":"9","key":"2024100104312423800_ref213","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/GME.0000000000001609","article-title":"The 2020 genitourinary syndrome of menopause position statement of the North American Menopause Society","volume":"27","author":"NAMS 2020 GMS Position Statement Editorial Paper","year":"2020","journal-title":"Menopause"},{"issue":"4","key":"2024100104312423800_ref214","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jsxm.2016.02.167","article-title":"2015 ISSVD, ISSWSH, and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia","volume":"13","author":"Bornstein","year":"2016","journal-title":"J Sex Med"},{"issue":"2","key":"2024100104312423800_ref215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/LGT.0000000000000461","article-title":"Descriptors of vulvodynia: a multisocietal definition consensus (International Society for the Study of vulvovaginal disease, the International Society for the Study of women sexual health, and the international pelvic pain society)","volume":"23","author":"Bornstein","year":"2019","journal-title":"J Low Genit Tract Dis"},{"issue":"3","key":"2024100104312423800_ref216","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1743-6109.2008.01153.x","article-title":"Validation of the decreased sexual desire screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD)","volume":"6","author":"Clayton","year":"2009","journal-title":"J Sex Med"},{"issue":"2","key":"2024100104312423800_ref217","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther"},{"issue":"2","key":"2024100104312423800_ref218","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1743-6109.2007.00672.x","article-title":"Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder","volume":"5","author":"Derogatis","year":"2008","journal-title":"J Sex Med"},{"issue":"6","key":"2024100104312423800_ref219","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/GME.0000000000002185","article-title":"Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update","volume":"30","author":"Meziou","year":"2023","journal-title":"Menopause"},{"key":"2024100104312423800_ref220","volume-title":"ADDYI [package insert]","year":", 2021"},{"key":"2024100104312423800_ref221","volume-title":"VYLEESI [Package Insert]","year":", 2021"},{"key":"2024100104312423800_ref222","volume-title":"ANDROFEME 1 [Australian Product Information]","year":", 2023"},{"key":"2024100104312423800_ref223","volume-title":"ESTRACE [Package Insert]","year":"2022"},{"key":"2024100104312423800_ref224","volume-title":"VAGIFEM [Package Insert]","year":", 2009"},{"key":"2024100104312423800_ref225","volume-title":"PREMARIN [Package Insert]","year":", 2018"},{"key":"2024100104312423800_ref226","volume-title":"OSPHENA [Package Insert]","year":", 2023"},{"key":"2024100104312423800_ref227","volume-title":"INTRAROSA [package insert]","year":", 2020"},{"key":"2024100104312423800_ref228","volume-title":"IMVEXXY [Package Insert]","year":", 2021"},{"key":"2024100104312423800_ref229","volume-title":"ESTRING [package insert]","year":", 2022"},{"issue":"1","key":"2024100104312423800_ref230","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsxm.2021.09.017","article-title":"Educational programs and sexual counselling for postmenopausal sexual dysfunction: a systematic review and meta-analysis","volume":"19","author":"Santos Silva","year":"2022","journal-title":"J Sex Med"},{"issue":"11","key":"2024100104312423800_ref231","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.jsxm.2016.09.009","article-title":"Cardiometabolic risk and female sexuality: focus on clitoral vascular resistance","volume":"13","author":"Maseroli","year":"2016","journal-title":"J Sex Med"},{"issue":"4","key":"2024100104312423800_ref232","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.sxmr.2018.03.004","article-title":"Cardiometabolic risk and female sexuality\u2014part II. Understanding (and overcoming) gender differences: the key role of an adequate methodological approach","volume":"6","author":"Maseroli","year":"2018","journal-title":"Sex Med Rev"},{"issue":"9","key":"2024100104312423800_ref233","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jsxm.2022.06.007","article-title":"Sexual dysfunction as a harbinger of cardiovascular disease in postmenopausal women: how far are we?","volume":"19","author":"Cipriani","year":"2022","journal-title":"J Sex Med"},{"issue":"1","key":"2024100104312423800_ref234","doi-asserted-by":"crossref","first-page":"18899","DOI":"10.1038\/s41598-021-98336-7","article-title":"Cardiometabolic risk is unraveled by color Doppler ultrasound of the clitoral and uterine arteries in women consulting for sexual symptoms","volume":"11","author":"Scavello","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"2024100104312423800_ref235","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/jch.14435","article-title":"Analysis of integrated clinical safety data of tadalafil in patients receiving concomitant antihypertensive medications","volume":"24","author":"Kloner","year":"2022","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2024100104312423800_ref236","doi-asserted-by":"crossref","first-page":"j2099","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/12\/4\/681\/59335201\/qeae043.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smr\/article-pdf\/12\/4\/681\/59335201\/qeae043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:02:37Z","timestamp":1732147357000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smr\/article\/12\/4\/681\/7700059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":236,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,6,27]]},"published-print":{"date-parts":[[2024,9,25]]}},"URL":"https:\/\/doi.org\/10.1093\/sxmrev\/qeae043","relation":{},"ISSN":["2050-0513","2050-0521"],"issn-type":[{"value":"2050-0513","type":"print"},{"value":"2050-0521","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,6,27]]}}}